» Articles » PMID: 39380213

Aggregation-Induced Emission Luminogen: Role in Biopsy for Precision Medicine

Overview
Journal Chem Rev
Specialty Chemistry
Date 2024 Oct 9
PMID 39380213
Authors
Affiliations
Soon will be listed here.
Abstract

Biopsy, including tissue and liquid biopsy, offers comprehensive and real-time physiological and pathological information for disease detection, diagnosis, and monitoring. Fluorescent probes are frequently selected to obtain adequate information on pathological processes in a rapid and minimally invasive manner based on their advantages for biopsy. However, conventional fluorescent probes have been found to show aggregation-caused quenching (ACQ) properties, impeding greater progresses in this area. Since the discovery of aggregation-induced emission luminogen (AIEgen) have promoted rapid advancements in molecular bionanomaterials owing to their unique properties, including high quantum yield (QY) and signal-to-noise ratio (SNR), . This review seeks to present the latest advances in AIEgen-based biofluorescent probes for biopsy in real or artificial samples, and also the key properties of these AIE probes. This review is divided into: (i) tissue biopsy based on smart AIEgens, (ii) blood sample biopsy based on smart AIEgens, (iii) urine sample biopsy based on smart AIEgens, (iv) saliva sample biopsy based on smart AIEgens, (v) biopsy of other liquid samples based on smart AIEgens, and (vi) perspectives and conclusion. This review could provide additional guidance to motivate interest and bolster more innovative ideas for further exploring the applications of various smart AIEgens in precision medicine.

Citing Articles

Aggregation-induced enhanced emission (AIEE), pH sensing and selective detection of sulfuric acid of novel imidazole-based surrogates made microwave-assisted synthesis.

Baig N, Shetty S, Parikh A, Sah A, Alameddine B RSC Adv. 2025; 15(8):5932-5941.

PMID: 39990816 PMC: 11844752. DOI: 10.1039/d5ra00786k.


Tuning the Chain Conformation of Pyrenyl-Pyridine Conjugated Oligomer Nanoprobe for Ultrasensitive Fluorescent Assaying of Fe and Ascorbic Acid.

Zhao Y, Wang H, Huang H, Chen M, Wen Y, Xiao Z J Fluoresc. 2025; .

PMID: 39945985 DOI: 10.1007/s10895-025-04158-5.

References
1.
Shi X, Yan N, Niu G, Sung S, Liu Z, Liu J . monitoring of tissue regeneration using a ratiometric lysosomal AIE probe. Chem Sci. 2021; 11(12):3152-3163. PMC: 8157324. DOI: 10.1039/c9sc06226b. View

2.
Wu X, Xu M, Geng M, Chen S, Little P, Xu S . Targeting protein modifications in metabolic diseases: molecular mechanisms and targeted therapies. Signal Transduct Target Ther. 2023; 8(1):220. PMC: 10224996. DOI: 10.1038/s41392-023-01439-y. View

3.
Tavazzi B, Lazzarino G, Leone P, Amorini A, Bellia F, Janson C . Simultaneous high performance liquid chromatographic separation of purines, pyrimidines, N-acetylated amino acids, and dicarboxylic acids for the chemical diagnosis of inborn errors of metabolism. Clin Biochem. 2005; 38(11):997-1008. DOI: 10.1016/j.clinbiochem.2005.08.002. View

4.
Lehmann D, Gomes B, Vetter N, Braun O, Amr A, Hilbel T . Prediction of diagnosis and diastolic filling pressure by AI-enhanced cardiac MRI: a modelling study of hospital data. Lancet Digit Health. 2024; 6(6):e407-e417. DOI: 10.1016/S2589-7500(24)00063-3. View

5.
Kim J, Tran V, Oh S, Jang M, Lee D, Hong J . Clinical Trial: Magnetoplasmonic ELISA for Urine-based Active Tuberculosis Detection and Anti-Tuberculosis Therapy Monitoring. ACS Cent Sci. 2021; 7(11):1898-1907. PMC: 8614099. DOI: 10.1021/acscentsci.1c00948. View